US6312921B1
(en)
|
1996-07-26 |
2001-11-06 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6818751B1
(en)
|
1997-08-01 |
2004-11-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6395278B1
(en)
|
1997-02-25 |
2002-05-28 |
Corixa Corporation |
Prostate specific fusion protein compositions
|
US6759515B1
(en)
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6894146B1
(en)
|
1997-02-25 |
2005-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6613872B1
(en)
|
1997-02-25 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US6620922B1
(en)
|
1997-02-25 |
2003-09-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
IL131560A0
(en)
|
1997-02-25 |
2001-01-28 |
Corixa Corp |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6630305B1
(en)
|
1999-11-12 |
2003-10-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
AU7807298A
(en)
*
|
1997-06-04 |
1998-12-21 |
Genetics Institute Inc. |
Secreted proteins and polynucleotides encoding them
|
EP1627886A1
(en)
*
|
1997-10-07 |
2006-02-22 |
Ono Pharmaceutical Co., Ltd. |
Polypeptide, cDNA encoding the same, and use of them
|
WO1999040193A1
(en)
*
|
1998-02-04 |
1999-08-12 |
Zymogenetics, Inc. |
Angiopoietin homolog zapo3, dna encoding it, and method of making it
|
US6610526B2
(en)
*
|
1998-03-13 |
2003-08-26 |
Inctye Corporation |
Human E1-like protein
|
US6277568B1
(en)
|
1998-04-09 |
2001-08-21 |
Incyte Genomics, Inc. |
Nucleic acids encoding human ubiquitin-conjugating enzyme homologs
|
CA2328489A1
(en)
*
|
1998-05-18 |
1999-11-25 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
PT1098972E
(en)
*
|
1998-07-22 |
2010-12-14 |
Smithkline Beecham Ltd |
Protein similar to neuroendocrine-specific protein, and encoding cdna
|
EP1104771A4
(en)
*
|
1998-08-07 |
2005-01-26 |
Ono Pharmaceutical Co |
NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
|
EP1105479B1
(en)
|
1998-08-11 |
2011-01-12 |
Darwin Discovery Limited |
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
WO2000032746A2
(en)
*
|
1998-11-30 |
2000-06-08 |
Millennium Pharmaceuticals, Inc. |
Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
|
WO2000063367A1
(en)
*
|
1999-04-15 |
2000-10-26 |
Warner-Lambert Company |
A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
|
GB9909161D0
(en)
*
|
1999-04-21 |
1999-06-16 |
Smithkline Beecham Plc |
Novel compounds
|
EP1183370A2
(en)
*
|
1999-05-20 |
2002-03-06 |
Incyte Genomics, Inc. |
Human oxidoreductase proteins
|
WO2000073458A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Zymogenetics, Inc. |
Secreted alpha-helical protein-31
|
EP1396543A3
(en)
*
|
1999-07-08 |
2004-03-31 |
Research Association for Biotechnology |
Primers for synthesizing full length cDNA clones and their use
|
EP1616879A3
(en)
*
|
1999-10-19 |
2006-11-29 |
Lexicon Genetics Incorporated |
Human cub-domain-containing protein and gene encoding the same
|
EP1226242A1
(en)
*
|
1999-10-19 |
2002-07-31 |
Lexicon Genetics Incorporated |
Human cub-domain-containing protein and gene encoding the same
|
EP1240198A4
(en)
*
|
1999-10-19 |
2003-11-05 |
Millennium Pharm Inc |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
FR2800750B1
(en)
*
|
1999-11-05 |
2003-01-31 |
Centre Nat Rech Scient |
MEMBRANE PROTEINS CTL (CHOLINE TRANSPORTER LIKE) INVOLVED IN THE TRANSPORT OF CHOLINE
|
CA2398251A1
(en)
*
|
2000-01-25 |
2001-08-02 |
Hyseq, Inc. |
Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
|
DK1967586T3
(en)
|
2000-01-26 |
2011-06-20 |
Agensys Inc |
84P2A9: prostate- and testicle-specific protein with high expression in prostate cancer
|
CA2394039A1
(en)
*
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
US7534417B2
(en)
|
2000-02-24 |
2009-05-19 |
Agensys, Inc. |
103P2D6: tissue specific protein highly expressed in various cancers
|
DE60130541T2
(en)
*
|
2000-02-24 |
2008-06-19 |
Agensys, Inc., Santa Monica |
TISSUE SPECIFIC PROTEIN 103P2D6, STRONG EXPRESSED IN DIFFERENT CANCER TYPES
|
JP2004527210A
(en)
|
2000-08-02 |
2004-09-09 |
ザ ジョンズ ホプキンス ユニバーシティー |
Evaluation method of endothelial cell expression pattern
|
US7048931B1
(en)
|
2000-11-09 |
2006-05-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7081344B2
(en)
|
2000-11-30 |
2006-07-25 |
Millennium Pharmaceuticals, Inc. |
Methods for screening compounds that bind human COE-2
|
WO2002064770A1
(en)
*
|
2001-02-15 |
2002-08-22 |
Mochida Pharmaceutical Co., Ltd. |
Novel scavenger receptor class a protein
|
US7927597B2
(en)
|
2001-04-10 |
2011-04-19 |
Agensys, Inc. |
Methods to inhibit cell growth
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US7449548B2
(en)
|
2001-12-07 |
2008-11-11 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
|
US20040081653A1
(en)
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
CA2618951A1
(en)
|
2005-08-12 |
2007-02-22 |
Schering Corporation |
Mcp1 fusions
|
ES2435917T3
(en)
|
2008-02-04 |
2013-12-26 |
Lay Line Genomics S.P.A. |
Anti-Trk-A antibodies and derivatives thereof
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|